Agios presents encouraging results of leukemia drug trial

04/6/2014 | Forbes · Reuters

In the first clinical trial of Agios' AG-221 for acute myeloid leukemia with a specific mutation, three out of the seven patients who completed the study experienced complete remission while the conditions of another three improved. The drug could help reduce the need for bone marrow transplants, said Dr. Eytan Stein, who presented the results at the 2014 American Association for Cancer Research meeting.

View Full Article in:

Forbes · Reuters

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Eastern Zone Sales Director
Regenesis Biomedical
Multiple Locations, SL_Multiple Locations
Director, Compliance - Health Plan Privacy & Security
Kaiser Permanente
Oakland, CA
Regulatory Counsel
Food and Drug Administration
Silver Spring, MD
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Vice President, Commercial Markets
Meridian Health
Neptune, NJ